Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 3:52 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 2,795 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Combination Group Clear all

Conditions: Tobacco Use
Interventions: e-cigarette, Nicotine patch, Nicotine lozenge; Behavioral · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Neuroendocrine Tumors
Interventions: Telotristat (Low-Dose), Telotristat (High-Dose); Drug
Lead sponsor: Lowell Anthony, MD; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Adult Solid Tumor
Interventions: SQZ-AAC-HPV, Ipilimumab, Nivolumab; Biological · Drug
Lead sponsor: SQZ Biotechnologies; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 6
States / cities: Duarte, California • La Jolla, California • Detroit, Michigan + 3 more

Conditions: Pain, Postoperative
Interventions: Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111), Naproxen Sodium 440 mg (BAYH6689), DPH 50 mg; Drug
Lead sponsor: Bayer; Industry
Eligibility: 12 Years and older
Enrollment: 267 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Austin, Texas • Salt Lake City, Utah

Conditions: Stroke
Interventions: REACH robotic training and multi-muscle Functional Electrical Stimulation (FES) group, Robot only group; Combination Product
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 22 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Myocardial Ischemia, Rheumatic Diseases
Interventions: Caplan IVR; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 95 Years
Enrollment: 5,269 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 4
States / cities: San Francisco, California • Aurora, Colorado • Baltimore, Maryland + 1 more

Conditions: Brain Concussion, Mild Traumatic Brain Injury
Interventions: Physical Therapy; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 13 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Orland Park, Illinois • Niagara Falls, New York

Conditions: Heart Failure
Interventions: ENGAGE-HF Mobile Application; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Stanford, California • Baltimore, Maryland • Ann Arbor, Michigan

Conditions: Obesity
Interventions: Communications, Pricing, Combined (Communications & Pricing); Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 21 Years to 100 Years
Enrollment: 444 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Mucositis, Neoplasms
Interventions: Oral Defense Toothpaste, Crest Toothpaste, Magic Mouth Rinse; Drug
Lead sponsor: Oral Defense, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Multiple Sclerosis, Adult Disease
Interventions: Home-based exercise, Education, Exercise plus Education; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 50 Years to 75 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Cerebral Palsy (CP), Dysarthria
Interventions: Speech only, Hand/Arm only, Speech and arm combined; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 8 Years to 17 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Obesity, Weight Loss
Interventions: Weight Stable Group; Behavioral
Lead sponsor: Wake Forest University; Other
Eligibility: 65 Years to 79 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Malignant Glioma, High Grade Glioma
Interventions: TTRNA-DC vaccines with GM-CSF, Dose-intensified TMZ, Autologous Hematopoietic Stem cells (HSCs), TTRNA-xALT, Td vaccine; Biological · Drug
Lead sponsor: University of Florida; Other
Eligibility: 3 Years to 21 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 3
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Gainesville, Florida

Conditions: Advanced Malignancies
Interventions: CDX-1401 in combination with Resiquimod and/or Poly-ICLC, CDX-1401, Resiquimod, poly-ICLC; Biological
Lead sponsor: Celldex Therapeutics; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 7
States / cities: New Haven, Connecticut • Miami Beach, Florida • Detroit, Michigan + 3 more

Conditions: Non-small Cell Lung Cancer
Interventions: ALT-803, Nivolumab; Biological
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 4
States / cities: Weston, Florida • Minneapolis, Minnesota • Cleveland, Ohio + 1 more

Conditions: Asthma
Interventions: Placebo, FP 100mcg, FP 250mcg, FP 500mcg, FSC 100/50mcg, FSC 250/50mcg, FSC500/50mcg; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Years and older
Enrollment: 446 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 51
States / cities: Birmingham, Alabama • Jasper, Alabama • Glendale, Arizona + 43 more

Conditions: Spinal Cord Injury Cervical
Interventions: Active Stimulation, Sham, Training only; Other
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Healthy
Interventions: Nestorone® /testosterone gel, Testosterone only gel; Drug
Lead sponsor: Kimberly Myer; Other
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Torrance, California • Seattle, Washington

Conditions: Atrial Fibrillation, Obesity and Obesity-related Medical Conditions
Interventions: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy, Anti-Obesity Medication (AOM) treatment; Procedure · Drug
Lead sponsor: Ali Aminian; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Pediatric Immuno-Tolerant Chronic Hepatitis B
Interventions: Entecavir, Lamivudine, Pegylated Interferon Alfa-2A; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 3 Years to 17 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 3
States / cities: Kansas City, Missouri • New York, New York • Philadelphia, Pennsylvania

Conditions: Stepped Care Cognitive Behavioral Therapy, Exercise, Physical Activity, Anxiety Depression
Interventions: Stepped Care Mental Health Counseling, Exercise Program; Behavioral
Lead sponsor: Colorado State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Human Immunodeficiency Virus
Interventions: 3BNC117, 10-1074, Placebo; Drug
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Disability
Interventions: RETAINWORKS; Other
Lead sponsor: Mathematica Policy Research, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 963 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Topeka, Kansas

Search by objective public record fields.

Quit or Switch: E-cigarette Study

Telotristat With Lutathera in Neuroendocrine Tumors

Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Evaluate Analgesic / Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain

Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke

Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications

The Role of Mechanical Diagnosis and Therapy in the Management of Concussion

Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure

Multi-level Communications and Access Strategies to Improve the Food Environment

Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositis

Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior

Speech and Arm Combined Exergame

Effect of High Protein Weight Loss for Seniors

Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer

GSK BHR Study (Sont - Second Study)

Combining Spinal Cord Transcutaneous Stimulation and Activity-based Training in Inpatient Rehabilitation to Facilitate Upper Limb Function of Individuals with Acute to Subacute Cervical Spinal Cord Injury

Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men

Metabolic Surgery for Atrial Fibrillation Elimination

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

Latinas Integrating Fitness and Therapy

3BNC117 and 10-1074 in HIV Uninfected Adults

RETAINWORKS Impact Evaluation